— Know what they know.
Not Investment Advice
Also trades as: RAONF (OTC) · $vol 0M

RAC.AX ASX

Race Oncology Limited
1W: -6.3% 1M: -10.3% 3M: -12.7% YTD: -21.6% 1Y: +57.4% 3Y: +93.0% 5Y: -40.9%
A$1.92 ($1.34)
+0.06 (+3.23%)
 
Weekly Expected Move ±5.3%
A$2 A$2 A$2 A$2 A$2
ASX · Healthcare · Biotechnology · Tech Score Sell · Power 36 · A$376.5M mcap · 128M float · 0.077% daily turnover

Balance Sheet Trends

Total Assets
$38M +117.8% ▲
5Y CAGR: +21.7%
Total Liabilities
$2M +11.1% ▲
5Y CAGR: +25.7%
Shareholders Equity
$36M +127.6% ▲
5Y CAGR: +21.6%
Cash & Investments
$34M +150.9% ▲
5Y CAGR: +29.8%
Total Debt
$0 +0.0% ▲
Net Debt
-$34M -150.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$6M$2M$17M$14M$34M
Short-Term Investments$28M$20M$0$0$0
Cash & ST Investments$34M$22M$17M$14M$34M
Net Receivables$62K$2M$106K$30K$78K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$34M$24M$17M$15M$35M
Property, Plant & Equip.$0$0$0$0$4K
Goodwill & Intangibles$3M$3M$3M$3M$2M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$1M
Total Non-Current Assets$3M$3M$3M$3M$3M
Total Assets$38M$27M$20M$17M$38M
— Liabilities —
Accounts Payable$834K$639K$1M$458K$458K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$160K$910K
Total Current Liabilities$1M$1M$2M$1M$2M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$48K$25K$28K
Total Non-Current Liabilities$0$0$48K$25K$28K
Total Liabilities$1M$1M$2M$1M$2M
— Equity —
Common Stock$62M$62M$67M$68M$101M
Retained Earnings-$34M-$44M-$57M-$62M-$73M
Accumulated OCI$8M$7M$9M$10M$9M
Total Stockholders Equity$36M$25M$18M$16M$36M
Total Liabilities & Equity$38M$27M$20M$17M$38M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$6M-$2M-$17M-$14M-$34M
Total Investments$28M$20M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms